Medical Care

Global Primary Antibodies and Reagents Market Research Report 2025

The global market for Primary Antibodies and Reagents was valued at US$ 49.3 million in the year 2024 and is projected to reach a revised size of US$ 68.2 million by 2031, growing at a CAGR of 4.8% during the forecast period.
The market for primary antibodies and reagents is experiencing significant growth and is expected to continue this trend in the coming years. Primary antibodies are essential tools in life science research and diagnostics, as they specifically bind to target antigens and enable the detection and analysis of specific proteins or molecules. Reagents, on the other hand, are substances used to facilitate specific reactions or processes in scientific experiments.
This report aims to provide a comprehensive presentation of the global market for Primary Antibodies and Reagents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Primary Antibodies and Reagents.
The Primary Antibodies and Reagents market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Primary Antibodies and Reagents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Primary Antibodies and Reagents companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
Rockland Immunochemicals
Biorbyt
Agilent
SouthernBiotech
Proteintech
Elabscience
Abcam
BD
Santa Cruz Biotechnology
Sigma Aldrich Corporation
Thermo Fisher Scientific
Abnova
R&D Systems
MBL
CST
Merk
Novus Biologicals
PeproTech
Cayman
AbMax Biotechnology
MABTech
KPL
Segment by Type
Polyclonal
Monoclonal
Segment by Application
ELISA
Western Blot
Immunostaining
Immunohistochemistry
Immunocytochemistry
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Primary Antibodies and Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Primary Antibodies and Reagents Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global Primary Antibodies and Reagents Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 ELISA
1.3.3 Western Blot
1.3.4 Immunostaining
1.3.5 Immunohistochemistry
1.3.6 Immunocytochemistry
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Primary Antibodies and Reagents Market Perspective (2020-2031)
2.2 Global Primary Antibodies and Reagents Growth Trends by Region
2.2.1 Global Primary Antibodies and Reagents Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Primary Antibodies and Reagents Historic Market Size by Region (2020-2025)
2.2.3 Primary Antibodies and Reagents Forecasted Market Size by Region (2026-2031)
2.3 Primary Antibodies and Reagents Market Dynamics
2.3.1 Primary Antibodies and Reagents Industry Trends
2.3.2 Primary Antibodies and Reagents Market Drivers
2.3.3 Primary Antibodies and Reagents Market Challenges
2.3.4 Primary Antibodies and Reagents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Primary Antibodies and Reagents Players by Revenue
3.1.1 Global Top Primary Antibodies and Reagents Players by Revenue (2020-2025)
3.1.2 Global Primary Antibodies and Reagents Revenue Market Share by Players (2020-2025)
3.2 Global Primary Antibodies and Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Primary Antibodies and Reagents Revenue
3.4 Global Primary Antibodies and Reagents Market Concentration Ratio
3.4.1 Global Primary Antibodies and Reagents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Primary Antibodies and Reagents Revenue in 2024
3.5 Global Key Players of Primary Antibodies and Reagents Head office and Area Served
3.6 Global Key Players of Primary Antibodies and Reagents, Product and Application
3.7 Global Key Players of Primary Antibodies and Reagents, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Primary Antibodies and Reagents Breakdown Data by Type
4.1 Global Primary Antibodies and Reagents Historic Market Size by Type (2020-2025)
4.2 Global Primary Antibodies and Reagents Forecasted Market Size by Type (2026-2031)
5 Primary Antibodies and Reagents Breakdown Data by Application
5.1 Global Primary Antibodies and Reagents Historic Market Size by Application (2020-2025)
5.2 Global Primary Antibodies and Reagents Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Primary Antibodies and Reagents Market Size (2020-2031)
6.2 North America Primary Antibodies and Reagents Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Primary Antibodies and Reagents Market Size by Country (2020-2025)
6.4 North America Primary Antibodies and Reagents Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Primary Antibodies and Reagents Market Size (2020-2031)
7.2 Europe Primary Antibodies and Reagents Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Primary Antibodies and Reagents Market Size by Country (2020-2025)
7.4 Europe Primary Antibodies and Reagents Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Primary Antibodies and Reagents Market Size (2020-2031)
8.2 Asia-Pacific Primary Antibodies and Reagents Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Primary Antibodies and Reagents Market Size by Region (2020-2025)
8.4 Asia-Pacific Primary Antibodies and Reagents Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Primary Antibodies and Reagents Market Size (2020-2031)
9.2 Latin America Primary Antibodies and Reagents Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Primary Antibodies and Reagents Market Size by Country (2020-2025)
9.4 Latin America Primary Antibodies and Reagents Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Primary Antibodies and Reagents Market Size (2020-2031)
10.2 Middle East & Africa Primary Antibodies and Reagents Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Primary Antibodies and Reagents Market Size by Country (2020-2025)
10.4 Middle East & Africa Primary Antibodies and Reagents Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Details
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad Primary Antibodies and Reagents Introduction
11.1.4 Bio-Rad Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.1.5 Bio-Rad Recent Development
11.2 Rockland Immunochemicals
11.2.1 Rockland Immunochemicals Company Details
11.2.2 Rockland Immunochemicals Business Overview
11.2.3 Rockland Immunochemicals Primary Antibodies and Reagents Introduction
11.2.4 Rockland Immunochemicals Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.2.5 Rockland Immunochemicals Recent Development
11.3 Biorbyt
11.3.1 Biorbyt Company Details
11.3.2 Biorbyt Business Overview
11.3.3 Biorbyt Primary Antibodies and Reagents Introduction
11.3.4 Biorbyt Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.3.5 Biorbyt Recent Development
11.4 Agilent
11.4.1 Agilent Company Details
11.4.2 Agilent Business Overview
11.4.3 Agilent Primary Antibodies and Reagents Introduction
11.4.4 Agilent Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.4.5 Agilent Recent Development
11.5 SouthernBiotech
11.5.1 SouthernBiotech Company Details
11.5.2 SouthernBiotech Business Overview
11.5.3 SouthernBiotech Primary Antibodies and Reagents Introduction
11.5.4 SouthernBiotech Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.5.5 SouthernBiotech Recent Development
11.6 Proteintech
11.6.1 Proteintech Company Details
11.6.2 Proteintech Business Overview
11.6.3 Proteintech Primary Antibodies and Reagents Introduction
11.6.4 Proteintech Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.6.5 Proteintech Recent Development
11.7 Elabscience
11.7.1 Elabscience Company Details
11.7.2 Elabscience Business Overview
11.7.3 Elabscience Primary Antibodies and Reagents Introduction
11.7.4 Elabscience Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.7.5 Elabscience Recent Development
11.8 Abcam
11.8.1 Abcam Company Details
11.8.2 Abcam Business Overview
11.8.3 Abcam Primary Antibodies and Reagents Introduction
11.8.4 Abcam Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.8.5 Abcam Recent Development
11.9 BD
11.9.1 BD Company Details
11.9.2 BD Business Overview
11.9.3 BD Primary Antibodies and Reagents Introduction
11.9.4 BD Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.9.5 BD Recent Development
11.10 Santa Cruz Biotechnology
11.10.1 Santa Cruz Biotechnology Company Details
11.10.2 Santa Cruz Biotechnology Business Overview
11.10.3 Santa Cruz Biotechnology Primary Antibodies and Reagents Introduction
11.10.4 Santa Cruz Biotechnology Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.10.5 Santa Cruz Biotechnology Recent Development
11.11 Sigma Aldrich Corporation
11.11.1 Sigma Aldrich Corporation Company Details
11.11.2 Sigma Aldrich Corporation Business Overview
11.11.3 Sigma Aldrich Corporation Primary Antibodies and Reagents Introduction
11.11.4 Sigma Aldrich Corporation Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.11.5 Sigma Aldrich Corporation Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Details
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Primary Antibodies and Reagents Introduction
11.12.4 Thermo Fisher Scientific Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Abnova
11.13.1 Abnova Company Details
11.13.2 Abnova Business Overview
11.13.3 Abnova Primary Antibodies and Reagents Introduction
11.13.4 Abnova Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.13.5 Abnova Recent Development
11.14 R&D Systems
11.14.1 R&D Systems Company Details
11.14.2 R&D Systems Business Overview
11.14.3 R&D Systems Primary Antibodies and Reagents Introduction
11.14.4 R&D Systems Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.14.5 R&D Systems Recent Development
11.15 MBL
11.15.1 MBL Company Details
11.15.2 MBL Business Overview
11.15.3 MBL Primary Antibodies and Reagents Introduction
11.15.4 MBL Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.15.5 MBL Recent Development
11.16 CST
11.16.1 CST Company Details
11.16.2 CST Business Overview
11.16.3 CST Primary Antibodies and Reagents Introduction
11.16.4 CST Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.16.5 CST Recent Development
11.17 Merk
11.17.1 Merk Company Details
11.17.2 Merk Business Overview
11.17.3 Merk Primary Antibodies and Reagents Introduction
11.17.4 Merk Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.17.5 Merk Recent Development
11.18 Novus Biologicals
11.18.1 Novus Biologicals Company Details
11.18.2 Novus Biologicals Business Overview
11.18.3 Novus Biologicals Primary Antibodies and Reagents Introduction
11.18.4 Novus Biologicals Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.18.5 Novus Biologicals Recent Development
11.19 PeproTech
11.19.1 PeproTech Company Details
11.19.2 PeproTech Business Overview
11.19.3 PeproTech Primary Antibodies and Reagents Introduction
11.19.4 PeproTech Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.19.5 PeproTech Recent Development
11.20 Cayman
11.20.1 Cayman Company Details
11.20.2 Cayman Business Overview
11.20.3 Cayman Primary Antibodies and Reagents Introduction
11.20.4 Cayman Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.20.5 Cayman Recent Development
11.21 AbMax Biotechnology
11.21.1 AbMax Biotechnology Company Details
11.21.2 AbMax Biotechnology Business Overview
11.21.3 AbMax Biotechnology Primary Antibodies and Reagents Introduction
11.21.4 AbMax Biotechnology Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.21.5 AbMax Biotechnology Recent Development
11.22 MABTech
11.22.1 MABTech Company Details
11.22.2 MABTech Business Overview
11.22.3 MABTech Primary Antibodies and Reagents Introduction
11.22.4 MABTech Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.22.5 MABTech Recent Development
11.23 KPL
11.23.1 KPL Company Details
11.23.2 KPL Business Overview
11.23.3 KPL Primary Antibodies and Reagents Introduction
11.23.4 KPL Revenue in Primary Antibodies and Reagents Business (2020-2025)
11.23.5 KPL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Primary Antibodies and Reagents Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Polyclonal
Table 3. Key Players of Monoclonal
Table 4. Global Primary Antibodies and Reagents Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Primary Antibodies and Reagents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Primary Antibodies and Reagents Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Primary Antibodies and Reagents Market Share by Region (2020-2025)
Table 8. Global Primary Antibodies and Reagents Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Primary Antibodies and Reagents Market Share by Region (2026-2031)
Table 10. Primary Antibodies and Reagents Market Trends
Table 11. Primary Antibodies and Reagents Market Drivers
Table 12. Primary Antibodies and Reagents Market Challenges
Table 13. Primary Antibodies and Reagents Market Restraints
Table 14. Global Primary Antibodies and Reagents Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Primary Antibodies and Reagents Market Share by Players (2020-2025)
Table 16. Global Top Primary Antibodies and Reagents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Antibodies and Reagents as of 2024)
Table 17. Ranking of Global Top Primary Antibodies and Reagents Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Primary Antibodies and Reagents Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Primary Antibodies and Reagents, Headquarters and Area Served
Table 20. Global Key Players of Primary Antibodies and Reagents, Product and Application
Table 21. Global Key Players of Primary Antibodies and Reagents, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Primary Antibodies and Reagents Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Primary Antibodies and Reagents Revenue Market Share by Type (2020-2025)
Table 25. Global Primary Antibodies and Reagents Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Primary Antibodies and Reagents Revenue Market Share by Type (2026-2031)
Table 27. Global Primary Antibodies and Reagents Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Primary Antibodies and Reagents Revenue Market Share by Application (2020-2025)
Table 29. Global Primary Antibodies and Reagents Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Primary Antibodies and Reagents Revenue Market Share by Application (2026-2031)
Table 31. North America Primary Antibodies and Reagents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Primary Antibodies and Reagents Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Primary Antibodies and Reagents Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Primary Antibodies and Reagents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Primary Antibodies and Reagents Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Primary Antibodies and Reagents Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Primary Antibodies and Reagents Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Primary Antibodies and Reagents Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Primary Antibodies and Reagents Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Primary Antibodies and Reagents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Primary Antibodies and Reagents Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Primary Antibodies and Reagents Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Primary Antibodies and Reagents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Primary Antibodies and Reagents Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Primary Antibodies and Reagents Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bio-Rad Company Details
Table 47. Bio-Rad Business Overview
Table 48. Bio-Rad Primary Antibodies and Reagents Product
Table 49. Bio-Rad Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 50. Bio-Rad Recent Development
Table 51. Rockland Immunochemicals Company Details
Table 52. Rockland Immunochemicals Business Overview
Table 53. Rockland Immunochemicals Primary Antibodies and Reagents Product
Table 54. Rockland Immunochemicals Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 55. Rockland Immunochemicals Recent Development
Table 56. Biorbyt Company Details
Table 57. Biorbyt Business Overview
Table 58. Biorbyt Primary Antibodies and Reagents Product
Table 59. Biorbyt Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 60. Biorbyt Recent Development
Table 61. Agilent Company Details
Table 62. Agilent Business Overview
Table 63. Agilent Primary Antibodies and Reagents Product
Table 64. Agilent Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 65. Agilent Recent Development
Table 66. SouthernBiotech Company Details
Table 67. SouthernBiotech Business Overview
Table 68. SouthernBiotech Primary Antibodies and Reagents Product
Table 69. SouthernBiotech Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 70. SouthernBiotech Recent Development
Table 71. Proteintech Company Details
Table 72. Proteintech Business Overview
Table 73. Proteintech Primary Antibodies and Reagents Product
Table 74. Proteintech Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 75. Proteintech Recent Development
Table 76. Elabscience Company Details
Table 77. Elabscience Business Overview
Table 78. Elabscience Primary Antibodies and Reagents Product
Table 79. Elabscience Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 80. Elabscience Recent Development
Table 81. Abcam Company Details
Table 82. Abcam Business Overview
Table 83. Abcam Primary Antibodies and Reagents Product
Table 84. Abcam Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 85. Abcam Recent Development
Table 86. BD Company Details
Table 87. BD Business Overview
Table 88. BD Primary Antibodies and Reagents Product
Table 89. BD Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 90. BD Recent Development
Table 91. Santa Cruz Biotechnology Company Details
Table 92. Santa Cruz Biotechnology Business Overview
Table 93. Santa Cruz Biotechnology Primary Antibodies and Reagents Product
Table 94. Santa Cruz Biotechnology Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 95. Santa Cruz Biotechnology Recent Development
Table 96. Sigma Aldrich Corporation Company Details
Table 97. Sigma Aldrich Corporation Business Overview
Table 98. Sigma Aldrich Corporation Primary Antibodies and Reagents Product
Table 99. Sigma Aldrich Corporation Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 100. Sigma Aldrich Corporation Recent Development
Table 101. Thermo Fisher Scientific Company Details
Table 102. Thermo Fisher Scientific Business Overview
Table 103. Thermo Fisher Scientific Primary Antibodies and Reagents Product
Table 104. Thermo Fisher Scientific Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 105. Thermo Fisher Scientific Recent Development
Table 106. Abnova Company Details
Table 107. Abnova Business Overview
Table 108. Abnova Primary Antibodies and Reagents Product
Table 109. Abnova Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 110. Abnova Recent Development
Table 111. R&D Systems Company Details
Table 112. R&D Systems Business Overview
Table 113. R&D Systems Primary Antibodies and Reagents Product
Table 114. R&D Systems Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 115. R&D Systems Recent Development
Table 116. MBL Company Details
Table 117. MBL Business Overview
Table 118. MBL Primary Antibodies and Reagents Product
Table 119. MBL Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 120. MBL Recent Development
Table 121. CST Company Details
Table 122. CST Business Overview
Table 123. CST Primary Antibodies and Reagents Product
Table 124. CST Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 125. CST Recent Development
Table 126. Merk Company Details
Table 127. Merk Business Overview
Table 128. Merk Primary Antibodies and Reagents Product
Table 129. Merk Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 130. Merk Recent Development
Table 131. Novus Biologicals Company Details
Table 132. Novus Biologicals Business Overview
Table 133. Novus Biologicals Primary Antibodies and Reagents Product
Table 134. Novus Biologicals Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 135. Novus Biologicals Recent Development
Table 136. PeproTech Company Details
Table 137. PeproTech Business Overview
Table 138. PeproTech Primary Antibodies and Reagents Product
Table 139. PeproTech Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 140. PeproTech Recent Development
Table 141. Cayman Company Details
Table 142. Cayman Business Overview
Table 143. Cayman Primary Antibodies and Reagents Product
Table 144. Cayman Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 145. Cayman Recent Development
Table 146. AbMax Biotechnology Company Details
Table 147. AbMax Biotechnology Business Overview
Table 148. AbMax Biotechnology Primary Antibodies and Reagents Product
Table 149. AbMax Biotechnology Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 150. AbMax Biotechnology Recent Development
Table 151. MABTech Company Details
Table 152. MABTech Business Overview
Table 153. MABTech Primary Antibodies and Reagents Product
Table 154. MABTech Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 155. MABTech Recent Development
Table 156. KPL Company Details
Table 157. KPL Business Overview
Table 158. KPL Primary Antibodies and Reagents Product
Table 159. KPL Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 160. KPL Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 164. Authors List of This Report


List of Figures
Figure 1. Primary Antibodies and Reagents Picture
Figure 2. Global Primary Antibodies and Reagents Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Primary Antibodies and Reagents Market Share by Type: 2024 VS 2031
Figure 4. Polyclonal Features
Figure 5. Monoclonal Features
Figure 6. Global Primary Antibodies and Reagents Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Primary Antibodies and Reagents Market Share by Application: 2024 VS 2031
Figure 8. ELISA Case Studies
Figure 9. Western Blot Case Studies
Figure 10. Immunostaining Case Studies
Figure 11. Immunohistochemistry Case Studies
Figure 12. Immunocytochemistry Case Studies
Figure 13. Other Case Studies
Figure 14. Primary Antibodies and Reagents Report Years Considered
Figure 15. Global Primary Antibodies and Reagents Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Primary Antibodies and Reagents Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Primary Antibodies and Reagents Market Share by Region: 2024 VS 2031
Figure 18. Global Primary Antibodies and Reagents Market Share by Players in 2024
Figure 19. Global Top Primary Antibodies and Reagents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Antibodies and Reagents as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Primary Antibodies and Reagents Revenue in 2024
Figure 21. North America Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Primary Antibodies and Reagents Market Share by Country (2020-2031)
Figure 23. United States Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Primary Antibodies and Reagents Market Share by Country (2020-2031)
Figure 27. Germany Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Primary Antibodies and Reagents Market Share by Region (2020-2031)
Figure 35. China Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Primary Antibodies and Reagents Market Share by Country (2020-2031)
Figure 43. Mexico Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Primary Antibodies and Reagents Market Share by Country (2020-2031)
Figure 47. Turkey Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Bio-Rad Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 51. Rockland Immunochemicals Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 52. Biorbyt Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 53. Agilent Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 54. SouthernBiotech Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 55. Proteintech Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 56. Elabscience Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 57. Abcam Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 58. BD Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 59. Santa Cruz Biotechnology Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 60. Sigma Aldrich Corporation Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 62. Abnova Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 63. R&D Systems Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 64. MBL Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 65. CST Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 66. Merk Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 67. Novus Biologicals Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 68. PeproTech Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 69. Cayman Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 70. AbMax Biotechnology Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 71. MABTech Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 72. KPL Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies